Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
Werte in diesem Artikel
Teladoc (TDOC) closed at $8.49 in the latest trading session, marking a +1.19% move from the prior day. The stock outpaced the S&P 500's daily gain of 1.08%. At the same time, the Dow added 0.92%, and the tech-heavy Nasdaq gained 1.41%.Coming into today, shares of the telehealth services provider had lost 36% in the past month. In that same time, the Medical sector gained 0.21%, while the S&P 500 lost 8.26%.Market participants will be closely following the financial results of Teladoc in its upcoming release. On that day, Teladoc is projected to report earnings of -$0.33 per share, which would represent year-over-year growth of 32.65%. Meanwhile, the latest consensus estimate predicts the revenue to be $618.17 million, indicating a 4.33% decrease compared to the same quarter of the previous year.For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.91 per share and a revenue of $2.51 billion, representing changes of +84.5% and -2.19%, respectively, from the prior year.Investors should also take note of any recent adjustments to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 7.92% higher within the past month. Teladoc is currently sporting a Zacks Rank of #3 (Hold).The Medical Services industry is part of the Medical sector. With its current Zacks Industry Rank of 71, this industry ranks in the top 29% of all industries, numbering over 250.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teladoc Health, Inc. (TDOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Teladoc und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Teladoc
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Teladoc
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Teladoc Inc
Analysen zu Teladoc Inc
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
05.06.2018 | Teladoc Buy | Canaccord Adams | |
15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
28.02.2018 | Teladoc Buy | Chardan Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
05.06.2018 | Teladoc Buy | Canaccord Adams | |
28.02.2018 | Teladoc Buy | Chardan Capital Markets | |
08.12.2017 | Teladoc Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
18.09.2017 | Teladoc Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teladoc Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen